Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Feb 2012 07:00

RNS Number : 3407X
Spectra Systems Corporation
14 February 2012
 



For immediate release

14 February 2012

 

 

Spectra Systems Corporation

 

("Spectra" or the "Company")

Appointment of Non-Executive Director

Spectra, a leading provider of advanced technology solutions for banknote and product authentication, is pleased to announce that on 13 February 2012 Jeffrey Donohue joined the Company as a Non-Executive director, replacing Mark Curcio, whose resignation as a Non-Executive director was announced on 10 February 2012.

Jeffrey Peter Donohue (aged 40) is Corporate Counsel for Novartis Institutes for BioMedical Research, Inc. ("NIBRI"), the research arm of the global healthcare products company Novartis. Mr. Donohue provides legal guidance on NIBRI's strategic acquisitions, licensing agreements, academic and government-backed consortia, and drug discovery collaborations. Mr. Donohue also is an Adjunct Professor at Boston University School of Law, USA, where he teaches advanced courses on licensing and intellectual property transactions.

 

Before joining NIBRI, Mr. Donohue served as Corporate Counsel at Vertex Pharmaceuticals Incorporated, a pharmaceutical company based in Cambridge, Massachusetts, USA. Mr. Donohue started his legal career at Kirkpatrick & Lockhart LLP (now K&L Gates), where he spent seven years advising clients on corporate governance, mergers and acquisitions, and securities matters. Mr. Donohue obtained his Juris Doctor from Boston University and a B.A. from Brandeis University.

Mr. Donohue was also a director of Raise The Sky Inc., from March 2009 until August 2010. There is no further information that is required to be disclosed in relation to Mr. Donohue pursuant to Schedule 2(g) of the AIM Rules for Companies.

Commenting on the appointment, Dr. Nabil Lawandy, Chief Executive of Spectra, said: "Jeff is a timely addition to the Spectra Board of Directors as we explore potential acquisitions and implement the next phase of our growth strategy."

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

 

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

Media Enquires:

The Communications Portfolio Limited

Ariane Comstive / Caolan Mahon Tel: +44 (0) 20 7536 2028 / 2029

ariane.comstive@communications-portfolio.co.uk

 

- Ends -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASFFFWDFESEFE
Date   Source Headline
1st Aug 20197:00 amRNSPolymer Banknote Substrate Supply Agreement
15th Jul 20197:00 amRNSNew Lottery Security Contracts
24th Jun 20197:00 amRNSAnnual General Meeting Lack of Quorum
11th Jun 20197:00 amRNSFive Year Optical Materials Supply Contract
29th May 20194:12 pmRNSExercise of Options
29th May 20197:00 amRNSTrading Update
28th May 20197:00 amRNSRemoval of Regulation S restrictions from shares
17th May 20193:21 pmRNSRemoval of Regulation S restrictions from shares
10th May 20192:31 pmRNSPosting of AGM Notice
10th May 20192:15 pmRNSShare Buy-Back
26th Apr 20198:55 amRNSPosting of Annual Report and Accounts
24th Apr 20197:00 amRNSRemoval of Regulation S Restrictions from Stock
18th Apr 20197:00 amRNSExercise of Options and Director/PDMR Shareholding
15th Apr 20197:00 amRNSUpdated CEO Employment Agreement
10th Apr 20197:00 amRNSShare Buy-Back Programme
25th Mar 20197:00 amRNSPreliminary Results
18th Mar 20197:00 amRNSTrading Update
22nd Feb 20199:04 amRNSDirector/PDMR Shareholding
19th Feb 201911:38 amRNSRemoval of Reg S restrictions from common stock
19th Feb 20197:00 amRNSDate of Audited Results
22nd Jan 20197:00 amRNSSensor Service Contract
11th Jan 20197:15 amRNSExercise of Options and Director/PDMR Shareholding
9th Jan 20197:00 amRNSExercise of Options and Director/PDMR Shareholding
2nd Jan 20197:00 amRNSFirst Orders for TruBrand in China
19th Dec 20184:16 pmRNSRemoval of Reg S restrictions from common stock
17th Dec 20187:00 amRNSChange of Registered Office
10th Dec 20187:44 amRNSTrading Update: Additional phosphour orders
20th Nov 20183:48 pmRNSExercise of Options
10th Oct 20182:37 pmRNSHolding(s) in Company
24th Sep 20187:00 amRNSInterim Results - Six Months End 30 June 2018
12th Sep 20189:58 amRNSRemoval of Reg S restrictions from common stock
3rd Sep 20187:00 amRNSTwo New Lottery Wins and Results Date
31st May 20184:03 pmRNSRemoval of Reg S restrictions from common stock
14th May 20187:00 amRNSG20 Central Bank begins Funding Sensor Development
24th Apr 20184:32 pmRNSPosting of Annual Report and Accounts
11th Apr 20187:00 amRNSExercise of Options
19th Mar 20187:00 amRNSPreliminary Results
1st Feb 20184:40 pmRNSSecond Price Monitoring Extn
1st Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20187:00 amRNSTrading Update
15th Jan 20187:00 amRNSLicensing Agreement and Supply Agreement
11th Dec 20177:00 amRNSAnnual General Meeting Postponed
10th Nov 20174:32 pmRNSHolding(s) in Company
23rd Oct 20173:44 pmRNSExercise of Options
16th Oct 20177:00 amRNSTrading Update
14th Sep 20175:34 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSInterim Results
21st Aug 20177:00 amRNSTrading Update and Interim Results Date
18th Jul 20177:00 amRNSRegulatory Approval for TruBrand Materials, China
7th Jul 20177:08 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.